A somatostatin analog improves tilt table tolerance by decreasing splanchnic vascular conductance

Journal of Applied Physiology

Volumn 112, Issue 9, 2012, Pages 1504-1511

  Jarvis, S S ^a   Florian, J P ^b   Curren, M J ^b   Pawelczyk, J A ^a,b  

^a Noll Laboratory   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Octreotide; Orthostatic intolerance; Splanchnic blood flow

Indexed keywords

OCTREOTIDE; VASOCONSTRICTOR AGENT;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD PRESSURE; BODY POSTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART RATE; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; INFUSION; KAPLAN MEIER METHOD; MALE; ORTHOSTATIC INTOLERANCE; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SEX DIFFERENCE; SPLANCHNIC BLOOD FLOW; SUPINE POSITION; TILT TABLE TEST; TIME; UNITED STATES;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BLOOD PRESSURE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HEMODYNAMICS; HUMANS; INFUSIONS, PARENTERAL; KAPLAN-MEIER ESTIMATE; MALE; OCTREOTIDE; ORTHOSTATIC INTOLERANCE; PENNSYLVANIA; POSTURE; RECOVERY OF FUNCTION; REGRESSION ANALYSIS; SEX FACTORS; SPLANCHNIC CIRCULATION; STROKE VOLUME; SUPINE POSITION; TILT-TABLE TEST; TIME FACTORS; VASOCONSTRICTOR AGENTS; YOUNG ADULT;

EID: 84862080639     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01475.2010     Document Type: Article

References (50)

1. Arbeille P, Kerbeci P, Mattar L, Shoemaker JK, Hughson R. Insufficient flow reduction during LBNP in both splanchnic and lower limb areas is associated with orthostatic intolerance after bedrest. Am J Physiol Heart Circ Physiol 295: H1846-H1854, 2008.
2. Arbeille PP, Besnard SS, Kerbeci PP, Mohty DM. Portal vein crosssectional area and flow and orthostatic tolerance: a 90-day bed rest study. J Appl Physiol 99: 1853-1857, 2005. (Pubitemid 41547183)
3. Banks WA, Schally AV, Barrera CM, Fasold MB, Durham DA, Csernus VJ, Groot K, Kastin AJ. Permeability of the murine blood-brain barrier to some octapeptide analogs of somatostatin. Proc Natl Acad Sci U S A 87: 6762-6766, 1990.
4. Bitar KN, Makhlouf GM. Selective presence of opiate receptors on intestinal circular muscle cells. Life Sci 37: 1545-1550, 1985. (Pubitemid 15239542)
5. Bosch J, Kravetz D, Rodes J. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Gastroenterology 80: 518-525, 1981. (Pubitemid 11183953)
6. Boulpaep EL. Regulation of arterial pressure and cardiac output. In: Medical Physiology, edited by Boron WF and Boulpaep EL. Philadelphia, PA: Saunders, 2003, p. 534-557.
7. Bowyer L, Brown MA, Jones M. Vascular reactivity in men and women of reproductive age. Am J Obstet Gynecol 185: 88-96, 2001. (Pubitemid 32681800)
8. Burke PG, Li Q, Costin ML, McMullan S, Pilowsky PM, Goodchild AK. Somatostatin 2A receptor-expressing presympathetic neurons in the rostral ventrolateral medulla maintain blood pressure. Hypertension 52: 1127-1133, 2008.
9. Convertino VA. Gender differences in autonomic functions associated with blood pressure regulation. Am J Physiol Regul Integr Comp Physiol 275: R1909-R1920, 1998.
10. Dorfman TA, Levine BD, Tillery T, Peshock RM, Hastings JL, Schneider SM, Macias BR, Biolo G, Hargens AR. Cardiac atrophy in women following bed rest. J Appl Physiol 103: 8-16, 2007. (Pubitemid 47092271)
11. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 17: 863-871, 1916.
12. Ergul A, Shoemaker K, Puett D, Tackett RL. Gender differences in the expression of endothelin receptors in human saphenous veins in vitro. J Pharmacol Exp Ther 285: 511-517, 1998. (Pubitemid 28237426)
13. Geelen G, Laitinen T, Hartikainen J, Lansimies E, Bergstrom K, Niskanen L. Gender influence on vasoactive hormones at rest and during a 70 degrees head-up tilt in healthy humans. J Appl Physiol 92: 1401-1408, 2002. (Pubitemid 34670892)
14. Grainger SL, Keeling PW, Brown IM, Marigold JH, Thompson RP. Clearance and non-invasive determination of the hepatic extraction of indocyanine green in baboons and man. Clin Sci (Lond) 64: 207-212, 1983. (Pubitemid 13141378)
15. Hirshoren N, Tzoran I, Makrienko I, Edoute Y, Plawner MM, Itskovitz-Eldor J, Jacob G. Menstrual cycle effects on the neurohumoral and autonomic nervous systems regulating the cardiovascular system. J Clin Endocrinol Metab 87: 1569-1575, 2002. (Pubitemid 34615241)
16. Hoeldtke RD, Bryner KD, Hoeldtke ME, Hobbs G. Treatment of postural tachycardia syndrome: a comparison of octreotide and midodrine. Clin Auton Res 16: 390-395, 2006. (Pubitemid 46009485)
17. Hoeldtke RD, Horvath GG, Bryner KD, Hobbs GR. Treatment of orthostatic hypotension with midodrine and octreotide. J Clin Endocrinol Metab 83: 339-343, 1998. (Pubitemid 28496502)
18. Jarvis SS, Florian JP, Curren MJ, Pawelczyk JA. Sex differences in vasoconstrictor reserve during 70 deg head-up tilt. Exp Physiol 95: 184-193, 2010.
19. Jarvis SS, Levine BD, Prisk GK, Shykoff BE, Elliott AR, Rosow E, Blomqvist CG, Pawelczyk JA. Simultaneous determination of the accuracy and precision of closed-circuit cardiac output rebreathing techniques. J Appl Physiol 103: 867-874, 2007. (Pubitemid 47358869)
20. Kalambokis G, Economou M, Fotopoulos A, Al Bokharhii J, Pappas C, Katsaraki A, Tsianos EV. The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites. Am J Gastroenterol 100: 879-885, 2005.
21. Katz MD, Erstad BL. Octreotide, a new somatostatin analogue. Clin Pharm 8: 255-273, 1989. (Pubitemid 19118919)
22. Kneale BJ, Chowienczyk PJ, Brett SE, Coltart DJ, Ritter JM. Gender differences in sensitivity to adrenergic agonists of forearm resistance vasculature. J Am Coll Cardiol 36: 1233-1238, 2000.
23. Law SF, Woulfe D, Reisine T. Somatostatin receptor activation of cellular effector systems. Cell Signal 7: 1-8, 1995.
24. Levine BD, Zuckerman JH, Pawelczyk JA. Cardiac atrophy after bed-rest deconditioning: a nonneural mechanism for orthostatic intolerance. Circulation 96: 517-525, 1997. (Pubitemid 27329428)
25. Meck JV, Waters WW, Ziegler MG, deBlock HF, Mills PJ, Robertson D, Huang PL. Mechanisms of postspaceflight orthostatic hypotension: low alpha1-adrenergic receptor responses before flight and central autonomic dysregulation postflight. Am J Physiol Heart Circ Physiol 286: H1486-H1495, 2004. (Pubitemid 38381159)
26. Milner TA, Pickel VM, Reis DJ. Ultrastructural basis for interactions between central opioids and catecholamines. I. Rostral ventrolateral medulla. J Neurosci 9: 2114-2130, 1989. (Pubitemid 19156997)
27. Minson CT, Halliwill JR, Young TM, Joyner MJ. Influence of the menstrual cycle on sympathetic activity, baroreflex sensitivity, and vascular transduction in young women. Circulation 101: 862-868, 2000. (Pubitemid 30117881)
28. Miyawaki T, Goodchild AK, Pilowsky PM. Activation of mu-opioid receptors in rat ventrolateral medulla selectively blocks baroreceptor reflexes while activation of delta opioid receptors blocks somato-sympathetic reflexes. Neuroscience 109: 133-144, 2002. (Pubitemid 34088152)
29. Montgomery LD, Kirk PJ, Payne PA, Gerber RL, Newton SD, Williams BA. Cardiovascular responses of men and women to lower body negative pressure. Aviat Space Environ Med 48: 138-145, 1977. (Pubitemid 8037272)
30. Murthy KS, Makhlouf GM. Opioid mu, delta, and kappa receptorinduced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle. Mol Pharmacol 50: 870-877, 1996. (Pubitemid 26347707)
31. Ottesen LH, Aagaard NK, Kiszka-Kanowitz M, Rehling M, Henriksen JH, Pedersen EB, Flyvbjerg A, Bendtsen F. Effects of a long-acting formulation of octreotide on renal function and renal sodium handling in cirrhotic patients with portal hypertension: a randomized, double-blind, controlled trial. Hepatology 34: 471-477, 2001. (Pubitemid 32786636)
32. Panes J, Pique JM, Bordas JM, Casadevall M, Teres J, Bosch J, Rodes J. Effect of bolus injection and continuous infusion of somatostatin on gastric perfusion in cirrhotic patients with portal-hypertensive gastropathy. Hepatology 20: 336-341, 1994. (Pubitemid 24233358)
33. Patel YC, Srikant CB. Somatostatin receptors. Trends Endocrinol Metab 8: 398-405, 1997. (Pubitemid 28160244)
34. Platts SH, Ziegler MG, Waters WW, Mitchell BM, Meck JV. Midodrine prescribed to improve recurrent post-spaceflight orthostatic hypotension. Aviat Space Environ Med 75: 554-556, 2004. (Pubitemid 38669456)
35. Reichlin S. Somatostatin. N Engl J Med 309: 1495-1501, 1983.
36. Reynaert H, Geerts A. Pharmacological rationale for the use of somatostatin and analogues in portal hypertension. Aliment Pharmacol Ther 18: 375-386, 2003. (Pubitemid 37070235)
37. Rowell LB. Human Circulation: Regulation During Physical Stress. New York: Oxford Press, 1986.
38. Rowell LB. Human Cardiovascular Control. New York: Oxford University Press, 1993.
39. Sabat M, Guarner C, Soriano G, Bulbena O, Novella MT, Ortiz J, Ricart E, Villanueva C, Rosello J, Rodriguez J, Balanzo J. Effect of subcutaneous administration of octreotide on endogenous vasoactive systems and renal function in cirrhotic patients with ascites. Dig Dis Sci 43: 2184-2189, 1998. (Pubitemid 28487245)
40. Sato T, Nishinaga M, Kawamoto A, Ozawa T, Takatsuji H. Accuracy of a continuous blood pressure monitor based on arterial tonometry. Hypertension 21: 866-874, 1993. (Pubitemid 23171651)
41. Sheppard M, Shapiro B, Pimstone B, Kronheim S, Berelowitz M, Gregory M. Metabolic clearance and plasma half-disappearance time of exogenous somatostatin in man. J Clin Endocrinol Metab 48: 50-53, 1979. (Pubitemid 9101608)
42. Shvartz E, Meyerstein N. Tilt tolerance of young men and young women. Aerospace Med 41: 253-255, 1970.
43. Sieber C, Gnadinger M, Del Pozo E, Shaw S, Weidmann P. Effect of a new somatostatin analogue SMS 201-995 (Sandostatin) on the reninaldosterone axis. Clin Endocrinol (Oxf) 28: 25-32, 1988. (Pubitemid 18027504)
44. Triebwasser JH, Johnson RL, Burpo RP, Campbell JC, Reardon WC, Blomqvist CG. Noninvasive determination of cardiac output by a modified acetylene rebreathing procedure utilizing mass spectrometer measurements. Aviat Space Environ Med 48: 203-209, 1977. (Pubitemid 8072442)
45. Watenpaugh DE, O'Leary DD, Schneider SM, Lee SM, Macias BR, Tanaka K, Hughson RL, Hargens AR. Lower body negative pressure exercise plus brief postexercise lower body negative pressure improve post-bed rest orthostatic tolerance. J Appl Physiol 103: 1964-1972, 2007. (Pubitemid 350232378)
46. Waters WW, Ziegler MG, Meck JV. Postspaceflight orthostatic hypotension occurs mostly in women and is predicted by low vascular resistance. J Appl Physiol 92: 586-594, 2002. (Pubitemid 34671024)
47. White DD, Montgomery LD. Pelvic blood pooling of men and women during lower body negative pressure. Aviat Space Environ Med 67: 555-559, 1996. (Pubitemid 26243374)
48. Wiest R, Tsai MH, Groszmann RJ. Octreotide potentiates PKC-dependent vasoconstrictors in portal-hypertensive and control rats. Gastroenterology 120: 975-983, 2001. (Pubitemid 32193194)
49. Wong BJ, Sheriff DD. Impact of a somatostatin analog on vascular capacity in conscious dogs (Abstract). FASEB J 21: A949, 2007.
50. Zidon TM, Sheriff DD. Diversion of blood flow from noncompliant to compliant vasculature in awake dogs: mechanical impact on right atrial pressure. Am J Physiol Heart Circ Physiol 290: H217-H223, 2006.